NEOS Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Hold |
3,904
| – | – | 0.01% | 548 |
|
|
2025
Q1 | $432K | Buy |
3,904
+58
| +2% | +$6.42K | 0.01% | 528 |
|
|
2024
Q4 | $525K | Hold |
3,846
| – | – | 0.01% | 497 |
|
|
2024
Q3 | $443K | Buy |
3,846
+294
| +8% | +$33.9K | 0.01% | 507 |
|
|
2024
Q2 | $489K | Hold |
3,552
| – | – | 0.02% | 457 |
|
|
2024
Q1 | $490K | Buy |
+3,552
| New | +$490K | 0.03% | 389 |
|